Lung Function Tests Market Research Report - Forecast till 2030

Lung Function Tests Market Information: By Type (Spirometry, Bronchial Provocation Test), Indication (Asthma, Chronic Bronchitis, Respiratory Infections, COPD, Cystic Fibrosis), Devices (Spirometer, Oscillometer), End-User - Forecast Till 2030

ID: MRFR/LS/3401-HCR | | Region: Global | 110 Pages         

Lung Function Tests Market

Lung Function Tests Market is expected to grow at a CAGR of 7.5% during the forecast period.

Segmentation

By Type Spirometry Bronchial Provocation Test
By Indication Asthma Chronic Bronchitis Respiratory Infections COPD Cystic Fibrosis
By Devices Spirometer Oscillometer

Key Players

  • MGC Diagnostic Corporation of the United States
  • Perkin Eimer of the United States
  • COSMED Srl of Italy
  • CareFusion Corporation of the United States
  • General Electric Company
  • NIHON KOHDEN CORPORATION of Japan

Drivers

  • Lung disease has become very much common nowadays
  • Increases the number of health-related problems like lung cancer
Speak to Analyst Request a Free Sample

Lung Function Tests Market Overview 


The Lung Function Tests Market is expected to reach USD 7650 Million by 2030 at 7.5% CAGR during the forecast period 2022-2030. Lung function tests diagnose disorders related to the lungs like asthma, some respiratory infections, chronic obstructive pulmonary disease, and many more. Lung function tests determine the functioning of the lungs and also determine the breathing rate of a person. These are the part of the lung tests routines so performed by the pulmonary doctors. They suggest performing lung tests for diagnosing diseases related to the lungs. They plan the treatment and decide whether they will continue with it or change it or will not perform the treatment. Before the operation, the type of lung function test plays a vital role in diagnosing several respiratory diseases and lung-related disorders.


The pulmonary testing devices are used for the identification of pulmonary impairment and some respiratory issues. An increase in air pollution and some of the climatic changes have accelerated the business sector. These devices are used for testing the rate of flow, measuring the lung volume capacity, and used for exchanging gas. These systems are used for diagnosing some of the lung disorders and are used for selecting therapeutics related to disorders of the lungs.


COVID 19 ANALYSIS 


The outbreak of COVID has hampered the ecosystem. It was marked that it majorly affected the respiratory system of the people. The most common symptoms observed by people who were affected by SARS CoV-2 are that they were unable to breathe properly and there was a lowering of oxygen level in them. The lung testing devices became a boom in the last year as these types of equipment were used for identifying the infection.


People throughout the world are suffering from this disease. This pandemic increased the demand for oxygen cylinders, testing kits, and ventilators. The government has discovered many applications that will help you to know whether you are affected by COVID or not. This has given a hike to the lung testing market.


MARKET DYNAMICS



  • Drivers- lung disease has become very much common nowadays. People are suffering from asthma, COPD, and many various pulmonary diseases. Availability of new and advanced devices for lung testing and rising demand for lung testing are the driving factors that accelerate the lung function tests market size. The growth of the old age population raises the market demand of Lung function tests market size. Transformation in lifestyle and people being much more addicted to smoking increases the number of health-related problems like lung cancer which impacts the lung function tests market size.

  • opportunities- Meagre growth segments in the industries help the consumers with valuable market overviews and the market insights help them for making the responsible decision for identifying the uses and the applications of the market. This provides great opportunities for growth and development.

  • Challenge- availability of branded raw materials is the major challenging factor affecting the lung function tests market growth. An increase in competition for local and for domestic brands is the most challenging factor. Domestic tariffs and some of the trade routes become a major challenging factor affecting the growth of lung function tests market size.

  • Cumulative growth- the rise in market value has brought a great change and has increased the demand of the lung function tests market. This growth has brought a change in healthcare scenarios.

  • Restraints- high costs of these devices and the systems have affected the market growth and also the lung function tests market size. The shortage of experts during the forecast period is the major restraining factor for the expansion of market size.


MARKET SEGMENTATION



  • By type- the pulmonary lung function tests market is classified into type, indication segment, devices, and end-users. Based on type, the lung tests market is divided into spirometry, gas diffusion test, body plethysmograph, a test of bronchial provocation, and many more. Moreover, it is also divided into portable PFT systems and complete PFT systems. Based on components, the pulmonary testing market is differentiated into software, hardware, and service. Based on indication, the lung tests units are classified into asthma, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, cancer of lungs, and many more. According to the devices, the market is also divided into a spirometer, monitoring breathes CO, oscillometry, and some of the dozes t5hat control drug nebulizer and many more. Based on end-users, the lung function tests market is classified into medicals, clinics, and some diagnostic services and centers.

  • By technology- use of innovative technology provided new opportunities to the lung function tests market players during the forecast period. It also helped in increasing the growth of the market segment. It helps them to take strategic decisions which will surely help in market growth. Penetration of new technology led to the increase in healthcare expenditure on capital investment. Technology installed base where its impact had on the lifeline curves and brought huge change on the production sites.


REGIONAL ANALYSIS 


America is said to be the most dominant lung functioning market where advanced tests are performed. People here are mostly affected by various types of allergies. As per the American College of Allergy Asthma and Immunology, of the United States, it was marked that people here were mostly affected by allergic asthma, food allergy, and eczema. Moreover, it was found that 1 in every 12 people are suffering from allergic rhinitis all over America. The European market is said to be the second-largest market covering a major portion of lung function tests market share. Moreover, in some of the regions of Europe allergy has become more prominent. Mostly here people suffer from asthma, food allergy, and anaphylaxis. So due to the allergy reactions being more prominent, people undergo diagnostic services. The rise in awareness concerning the available treatments and skin testing propels up the lung function tests market size. 


According to the European Academy of Allergy and Clinical Immunology, at least 150 million Europeans suffer from chronic disorders.  The Asian Pacific region grows at a very rapid rate and is moreover driven by rising in asthmatic patients and an increase in the growth of the aging population. The rise in lung function tests market size also increases with the fuelling up of the environmental population. Weakening immune response of the body highly prevalent asthmatic disorders are the maximum risk factors for people suffering from allergic reactions among the high age population. COPD being the most famous disorder boosts up the market lung function tests market size steers up the market size. Some of the Middle Eastern regions along with African regions show an exponential growth curve in the overall pulmonary lung function tests market thus leading to the high prevalence of chronic diseases and enhancing the healthcare structure. As per the lung function, test market trends rise in demand for diagnostic services has an influential growth on the pulmonary lung function tests market growth, especially in this region.


COMPETITIVE LANDSCAPE 


Some of the major key players playing in the lung function tests market are MGC Diagnostic Corporation of the United States, Perkin Eimer of the United States, COSMED Srl of Italy, CareFusion Corporation of the United States, General Electric Company, NIHON KOHDEN CORPORATION of Japan, and many more. These key players understood the competition going on in the market and provided a good analysis of the competitors. The competitive landscape includes the company's overview, the company's profile, and the portfolio of the key players.


REPORT OVERVIEW 


Lung function tests market report gives good analysis and insights concerning the various factors which remain prevalent during the market forecast period. It gives information about its impact on the whole of the population. The report gives detailed information about the new and innovative recent developments, gives a good analysis of export and import business, about the units that occupy a good lung function, tests market share, gives analysis about the key players and many more. It gives information about the growth factors and the application niches, product launches and also gives information about the geographic and regional expansion. It also summarises the new and innovative technology.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 7650 Million
  CAGR   7.5%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Indication, Devices
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of lung diseases
  • Availability of lung function test devices
  • Increasing demand for lung function tests
  • Technological advancements in lung testing
  • Growing geriatric population
  • Changing lifestyle, and smoking addiction


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Some of them are the manufacturers of drugs for lung treatment, suppliers of drugs, investors investing certain sums on lung treatment, companies dealing with research and development, laboratories dealing with medical research, and also includes some of the providers dealing with market research and consulting services.

    It gives a good analysis about the current and the future lung function tests market trends, some of the production sites, costs of the raw materials, and also about the investment done by the government.

    The market gives a detailed analysis of the capital investment for improving the quality and growth of the market. The market has installed the infrastructural base for using different kinds of products for testing the devices in the market.